Nureca Peer Comparison

NSE: NURECA | BSE: 543264

₹323.35

₹-0.05 (-0.02%)

As on 14-Oct-2026IST

Market cap

₹311 Cr

Revenue (TTM)

₹153 Cr

P/E Ratio

71.7

P/B Ratio

1.7

Div. Yield

0 %

Edit

	Nureca	Poly Medicure	QMS Medical	Alan Scott	Raaj Medisafe
Market cap (₹ Cr)	311	16,156	331	200	174
Revenue (₹ Cr)	153	1,997	183	34	94
Net Profit (₹ Cr)	4.34	307.01	12.72	-4.78	2.37
Net Margin (%)	2.70	14.56	6.90	-13.48	2.51
RoE (%)	2.29	10.63	10.39	-30.48	6.25
Price to Earnings	71.70	51.28	30.38	--	73.48
Price-To-Book	1.69	5.08	--	11.40	3.57

Income Statement (₹ Cr)

	Nureca	Poly Medicure	QMS Medical	Alan Scott	Raaj Medisafe
Operating Revenue	146.96	1,875.26	--	28.69	62.42
Total Income	155.06	2,002.19	--	30.94	62.73
Total Expenditure	146.78	1,436.66	--	26.75	53.90
EBITDA	0.18	438.59	--	1.94	8.52
Depreciation	2.02	115.52	--	3.80	1.45
EBIT	-1.84	323.08	--	-1.86	7.07
Interest	1.28	21.42	--	2.20	2.13
Other Income	8.10	126.93	--	2.25	0.31
Exceptional Items	--	-6.80	--	--	--
Profit before Tax	4.98	427.47	--	-1.82	5.25
Provision for Tax	2.90	106.74	--	--	-0.88
Profit after Tax	2.08	320.73	--	-1.82	6.13

	Nureca	Poly Medicure	QMS Medical	Alan Scott	Raaj Medisafe
Shareholder's Funds	180.76	3,106.17	--	1.77	26.92
Minority Interest	--	43.07	--	-0.58	--
Non-Current Liabilities	-0.92	120.16	--	19.69	13.28
Current Liabilities	13.78	666.53	--	6.37	27.87
Total Liabilities	196.16	3,951.60	--	27.25	69.22

	Nureca	Poly Medicure	QMS Medical	Alan Scott	Raaj Medisafe
Non-Current Assets	78.94	1,903.19	--	18.03	38.44
Current Assets	114.68	2,032.74	--	9.21	29.62
Total Assets	196.16	3,951.60	--	27.25	69.22
Total Debt*	0.72	341.62	--	7.38	34.51
Net Current Assets	100.90	1,366.21	--	2.85	1.75
Contingent Liabilities	4.73	50.21	--	--	0.36

	Nureca	Poly Medicure	QMS Medical	Alan Scott	Raaj Medisafe
Cash From Operating Activities	3.30	246.37	--	-1.68	-0.09
Cash Flow from Investing Activities	14.49	-225.38	--	1.92	-16.42
Cash from Financing Activities	-19.56	20.15	--	-1.98	16.52
Net Cash Inflow / Outflow	-1.77	41.14	--	-1.74	0.02

	Nureca	Poly Medicure	QMS Medical	Alan Scott	Raaj Medisafe
ROCE (%)	3.31	14.05	--	3.64	15.05
ROE (%)	1.11	10.94	--	-71.25	32.48
ROA (%)	1.04	8.89	--	-6.59	11.21
EBIT Margin (%)	5.63	30.16	--	14.60	14.15
Net Margin (%)	1.34	16.02	--	-5.87	9.77
Cash Profit Margin (%)	2.57	23.12	--	6.93	12.14

	Nureca	Poly Medicure	QMS Medical	Alan Scott	Raaj Medisafe
Revenue Growth (%)	34.02	12.30	--	149.39	44.33
EBIT Growth (%)	69.11	3.80	--	1,282.42	31.98
Net Profit Growth (%)	145.86	-5.27	--	48.05	84.20
EPS Growth (%)	157.91	-4.88	--	48.32	52.40
Book Value Growth (%)	-6.96	12.14	--	-46.81	148.37

	Nureca	Poly Medicure	QMS Medical	Alan Scott	Raaj Medisafe
Price / Earnings	94.46	37.47	--	0.00	15.80
Price / Book Value	1.09	3.90	--	36.61	3.60
Dividend Yield (%)	0.00	0.29	--	0.00	0.00
EV/EBITDA	18.84	21.79	--	17.05	14.87
Market Cap (₹ Cr)	196.67	12,069.92	--	64.81	96.86

	Nureca	Poly Medicure	QMS Medical	Alan Scott	Raaj Medisafe
Debt to Equity	0.00	0.11	--	4.17	1.28
Short term debt to equity ratio	0.00	0.08	--	0.16	0.75
Current Ratio	8.32	3.05	--	1.45	1.06
Quick Ratio	4.88	2.40	--	0.79	0.77
Interest Coverage	4.88	20.96	--	0.17	3.47

	Nureca	Poly Medicure	QMS Medical	Alan Scott	Raaj Medisafe
Debtors to sales (%)	5.27	28.33	--	2.17	26.75
Asset Turnover	0.80	0.52	--	1.04	1.14
Receivable days	12.70	85.20	--	6.55	71.88
Inventory Days	100.27	69.58	--	52.69	48.55
Payable days	22.92	77.97	--	33.92	20.86
Cash Conversion Cycle	90.04	76.82	--	25.31	99.57

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.